CDT Equity (CDT) Cash & Equivalents (2021 - 2026)
CDT Equity (CDT) recorded Cash & Equivalents of $747,000 in Q2 2026, down 77.6% from $3.33 million a year earlier but up 670.1% from the prior quarter.
Powered by 
Analysis
CDT Equity (CDT) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, CDT Equity reported Cash & Equivalents of $1.51 million, up 172.4% from FY2024.
- Annual Cash & Equivalents has a four-year compound annual growth rate of 136.1% (FY2021 to FY2025).
- Across earlier years, Cash & Equivalents came in at $554,000 in FY2024 (-86.9%), $4.23 million in FY2023, $345,777 in FY2022 (+612.1%) and $48,555 in FY2021.
- Quarterly Cash & Equivalents has ranged from $48,555 in Q4 2021 to $8.64 million in Q3 2023 over the past five years.
- On a year-over-year basis, Cash & Equivalents rose in two of the last six quarters, with an average decline of 28.5%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 612.1% in Q4 2022, against a decline of 99.2% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $97,000 (Q1 2026), $1.51 million (Q4 2025) and $3.84 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | CDT Equity | 34,330.48 | 34,330.48 | - | 747,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 747,000.00 |
| Mar 31, 2026 | 97,000.00 |
| Dec 31, 2025 | 1.51 Mn |
| Sep 30, 2025 | 3.84 Mn |
| Jun 30, 2025 | 3.33 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Dec 31, 2024 | 554,000.00 |
| Sep 30, 2024 | 71,000.00 |
| Jun 30, 2024 | 219,000.00 |
| Mar 31, 2024 | 1.84 Mn |
| Dec 31, 2023 | 4.23 Mn |
| Sep 30, 2023 | 8.64 Mn |
| Jun 30, 2023 | 277,761.00 |
| Mar 31, 2023 | 90,606.00 |
| Dec 31, 2022 | 345,777.00 |
| Sep 30, 2022 | 728,072.00 |
| Jun 30, 2022 | 837,687.00 |
| Mar 31, 2022 | 964,602.00 |
| Dec 31, 2021 | 48,555.00 |
API Access
CDT Equity Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CDT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CDT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CDT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();